chr11-113207325-C-T

Variant summary

Our verdict is Benign. Variant got -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BS1BS2

The NM_181351.5(NCAM1):​c.693C>T​(p.Val231=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0144 in 1,614,026 control chromosomes in the GnomAD database, including 204 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.0098 ( 8 hom., cov: 32)
Exomes 𝑓: 0.015 ( 196 hom. )

Consequence

NCAM1
NM_181351.5 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 0.117
Variant links:
Genes affected
NCAM1 (HGNC:7656): (neural cell adhesion molecule 1) This gene encodes a cell adhesion protein which is a member of the immunoglobulin superfamily. The encoded protein is involved in cell-to-cell interactions as well as cell-matrix interactions during development and differentiation. The encoded protein plays a role in the development of the nervous system by regulating neurogenesis, neurite outgrowth, and cell migration. This protein is also involved in the expansion of T lymphocytes, B lymphocytes and natural killer (NK) cells which play an important role in immune surveillance. This protein plays a role in signal transduction by interacting with fibroblast growth factor receptors, N-cadherin and other components of the extracellular matrix and by triggering signalling cascades involving FYN-focal adhesion kinase (FAK), mitogen-activated protein kinase (MAPK), and phosphatidylinositol 3-kinase (PI3K). One prominent isoform of this gene, cell surface molecule CD56, plays a role in several myeloproliferative disorders such as acute myeloid leukemia and differential expression of this gene is associated with differential disease progression. For example, increased expression of CD56 is correlated with lower survival in acute myeloid leukemia patients whereas increased severity of COVID-19 is correlated with decreased abundance of CD56-expressing NK cells in peripheral blood. Alternative splicing results in multiple transcript variants encoding distinct protein isoforms. [provided by RefSeq, Aug 2020]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -19 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.32).
BP6
Variant 11-113207325-C-T is Benign according to our data. Variant chr11-113207325-C-T is described in ClinVar as [Benign]. Clinvar id is 770406.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.117 with no splicing effect.
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.00975 (1486/152360) while in subpopulation NFE AF= 0.0159 (1083/68032). AF 95% confidence interval is 0.0151. There are 8 homozygotes in gnomad4. There are 700 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High AC in GnomAd4 at 1486 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
NCAM1NM_181351.5 linkuse as main transcriptc.693C>T p.Val231= synonymous_variant 6/20 ENST00000316851.12

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
NCAM1ENST00000316851.12 linkuse as main transcriptc.693C>T p.Val231= synonymous_variant 6/205 NM_181351.5 P3P13591-2

Frequencies

GnomAD3 genomes
AF:
0.00975
AC:
1485
AN:
152242
Hom.:
8
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00273
Gnomad AMI
AF:
0.00877
Gnomad AMR
AF:
0.0101
Gnomad ASJ
AF:
0.00778
Gnomad EAS
AF:
0.000192
Gnomad SAS
AF:
0.00704
Gnomad FIN
AF:
0.00367
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.0159
Gnomad OTH
AF:
0.0115
GnomAD3 exomes
AF:
0.00979
AC:
2441
AN:
249266
Hom.:
21
AF XY:
0.0102
AC XY:
1373
AN XY:
135232
show subpopulations
Gnomad AFR exome
AF:
0.00316
Gnomad AMR exome
AF:
0.00744
Gnomad ASJ exome
AF:
0.00735
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00533
Gnomad FIN exome
AF:
0.00450
Gnomad NFE exome
AF:
0.0152
Gnomad OTH exome
AF:
0.0140
GnomAD4 exome
AF:
0.0149
AC:
21710
AN:
1461666
Hom.:
196
Cov.:
31
AF XY:
0.0145
AC XY:
10561
AN XY:
727114
show subpopulations
Gnomad4 AFR exome
AF:
0.00254
Gnomad4 AMR exome
AF:
0.00780
Gnomad4 ASJ exome
AF:
0.00635
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00581
Gnomad4 FIN exome
AF:
0.00442
Gnomad4 NFE exome
AF:
0.0176
Gnomad4 OTH exome
AF:
0.0132
GnomAD4 genome
AF:
0.00975
AC:
1486
AN:
152360
Hom.:
8
Cov.:
32
AF XY:
0.00939
AC XY:
700
AN XY:
74518
show subpopulations
Gnomad4 AFR
AF:
0.00272
Gnomad4 AMR
AF:
0.0101
Gnomad4 ASJ
AF:
0.00778
Gnomad4 EAS
AF:
0.000193
Gnomad4 SAS
AF:
0.00725
Gnomad4 FIN
AF:
0.00367
Gnomad4 NFE
AF:
0.0159
Gnomad4 OTH
AF:
0.0114
Alfa
AF:
0.0129
Hom.:
3
Bravo
AF:
0.0102
Asia WGS
AF:
0.00404
AC:
14
AN:
3478
EpiCase
AF:
0.0166
EpiControl
AF:
0.0161

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpAug 11, 2018- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.32
CADD
Benign
8.2
DANN
Benign
0.69

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs17115156; hg19: chr11-113078047; COSMIC: COSV57510452; COSMIC: COSV57510452; API